daridorexant

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…

3 weeks ago

Idorsias daridorexant in women during menopausal transition age with insomnia

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared…

1 month ago